• Police seek suspects in deadly birthday party shooting
  • Lawmakers launch inquires into U.S. boat strike
  • Nov. 29, 2025, 10:07 PM EST / Updated Nov. 30, 2025,…
  • Mark Kelly says troops ‘can tell’ what orders…

Be that!

contact@bethat.ne.com

 

Be That ! Menu   ≡ ╳
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics Politics
☰

Be that!

Officials say Dallas shooter used ICE tracking apps

admin - Latest News - September 25, 2025
admin
38 views 8 secs 0 Comments



An ICE official says that the Dallas shooter used ICE tracking apps.



Source link

TAGS:
PREVIOUS
Trump signs executive order facilitating TikTok deal
NEXT
Trump jokes he would make TikTok algorithm '100% MAGA'
Related Post
October 14, 2025
Gaza nurse shot in the head while on duty
November 8, 2025
Savewith a NBCUniversal ProfileCreate your free profile or log in to save this articleNov. 8, 2025, 5:00 AM ESTBy Mithil AggarwalNEW DELHI — When the weight loss drug Mounjaro came on the market in India earlier this year, Shyamanthak Kiran was one of the first patients to try it.Kiran, a 27-year-old financial trader who has struggled with hypothyroidism, said he “did not have a lot of expectations” when it came to losing weight. But “luck turned out in my favor,” he said, and in six months he lost all of the 60-plus pounds he had gained a few years earlier.“It was a two-year struggle that came to an end, and I couldn’t be happier,” he told NBC News.Indians trying to lose weight are embracing drugs such as Mounjaro, which is also used to treat diabetes in a country that has been called the world’s diabetes capital. The injectable medication from American pharmaceutical company Eli Lilly has become India’s most popular drug by value since being approved in March, with over $11 million in sales in October, pharmaceutical market research firm Pharmarack said Friday.Mounjaro is an injectable medication used to treat diabetes. Saumya Khandelwal for NBC NewsEven before India’s more recent approval of Ozempic, another drug that is widely used for weight loss in the United States and other countries, there was already surging demand in the country for semaglutide, its active ingredient.Ozempic’s Danish drugmaker, Novo Nordisk, says it is “actively working” to widen the availability of the drug, which Indian regulators have approved for diabetes but not obesity. The company also makes other semaglutide drugs that are already used for weight loss in India, including Wegovy, an injectable, and Rybelsus, which is taken orally.Demand could grow even further when the patent for Ozempic’s active ingredient, semaglutide, expires next March in India, a pharmaceutical manufacturing giant where companies are eager to produce cheaper generic versions of the lucrative weight-loss drugs.The exploding popularity of the drugs has taken aback some doctors and officials, with Jitendra Singh, a government minister and physician, warning in August against the “unchecked spread of disinformation” through “fad regimens” and emphasizing the importance of lifestyle interventions such as regular yoga practice.Semaglutide and tirzepatide, the active ingredient in Mounjaro, are GLP-1 agonists that were first developed to treat diabetes and have also been approved in many countries for the treatment of obesity. They regulate blood sugar and help slow how quickly food passes through the stomach, curbing hunger as a result.India, the world’s most populous country, has over 100 million people with diabetes, or nearly 10% of its adult population, according to a 2023 study by the Indian Council of Medical Research. An additional 135 million people are prediabetic, the study found.Diabetes information displayed on the walls of a clinic in New Delhi last month.Saumya Khandelwal for NBC NewsDoctors say the situation is worsening as India’s burgeoning middle class adopts a more Western lifestyle, eating more high-fat, high-sugar foods and exercising less.“Compared to, say, a decade ago, there are more people now in their late 20s and early 30s who are being diagnosed with diabetes, as compared to the elderly population,” said Dr. Saurav Shishir Agrawal, an endocrinologist in Noida, which is part of Delhi’s capital region.“They ask us to just give them pills,” Agrawal said, “but these medicines work better only when you are clubbing them with lifestyle changes.”Agrawal practices at the newly built Medanta Hospital, where staff greet patients with a gentle “Namaste.” It is an example of the growing number of modern and high-end hospitals popping up around increasingly dense megacities such as Delhi, home to 33 million people, where diabetes has a greater hold.Saurav Agrawal, an endocrinologist at Medanta Hospital in Noida, India.Saumya Khandelwal for NBC NewsA monthly course of Mounjaro can cost as much as $250, the average monthly salary in many parts of India. But for more affluent Indians, a bigger deterrent is the idea of injecting themselves, said Dr. Tribhuvan Gulati, an endocrinologist.“People get scared whenever you tell them that they’re going to be on an injectable,” said Gulati, who has a clinic in central Delhi.Gulati keeps a demo pen of Mounjaro in a drawer to show how easy it is to use the medicine, which just needs to be refrigerated before use.But the ease of use is also what worries Gulati and other doctors, who say many patients fail to overhaul the lifestyle and dietary habits causing or contributing to their health issues in the first place.“If you look at the causes of obesity in India, it is 90% lifestyle and 10% anything else,” said Dr. Anoop Misra, chairman of the Fortis Centre for Diabetes, Obesity and Cholesterol and head of India’s National Diabetes Obesity and Cholesterol Foundation.“The diet now is totally imbalanced because of free availability of food everywhere,” he said.The potential gastrointestinal and other side effects from the weight-loss drugs, which in the U.S. have prompted multiple lawsuits against GLP-1 makers, give some patients pause, Gulati said. But others “are OK with continuing it throughout their life because they know that they won’t be able to control themselves.”A handbook about managing diabetes at a clinic in New Delhi.Saumya Khandelwal for NBC NewsDiabetic patients such as Moinak Pal, who has high insulin resistance, say that GLP-1 drugs have been the easiest way to lose weight.“I have been fat-shamed since I was a child,” said Pal, 34, a Noida-based journalist. He said he has been losing about 3 pounds a week since he started taking Mounjaro.It was “extremely difficult for me to lose weight by conventional means,” he said.Part of the problem, Misra said, is the lifestyle in India’s sprawling and congested urban areas, where commutes can last as long as four hours round-trip. When workers get home, apps can deliver everything from food to clothes to their doorsteps in minutes.“They want quick fixes that don’t involve going on a restrictive diet or daily exercise of an hour and so on,” he said of some of his patients. “As a result, diabetes is everywhere. Every day I see patients who are young, who have uncontrolled Type 2 diabetes.”Rajendra Nath Dixit blames nobody but himself for his health problems. The retired banker had heart bypass surgery earlier this year, and before that had been spending almost 8,000 rupees ($90) a month just on his insulin.“I was fond of taking the typical Indian oily foods, samosas, chole bhature, and in the evening I would take five or six rotis,” said Dixit, 66. “Every bad habit was there.”In the five months since his surgery, Dixit has switched over completely to the oral semaglutide Rybelsus, is exercising more and is consuming less fat and sugar. He is spending 11,000 rupees ($125) a month on Rybelsus, but has been able to stop using insulin.“I’m feeling very good, very light,” he said. “My confidence has gone up, and my life has totally changed.”Mithil AggarwalMithil Aggarwal is a Hong Kong-based reporter/producer for NBC News.
November 19, 2025
Nov. 18, 2025, 2:45 PM ESTBy Jared PerloThe robot warriors are coming, and so are the zillionaires, Sen. Bernie Sanders, I-Vt., warned in a wide-ranging interview with NBC News on the rise and risks of artificial intelligence.“I think we are not all that far away from the development of robotic soldiers,” Sanders said Sunday. “Right now, politicians — at least sometimes — have to worry about loss of life when they decide to go to war. If you don’t have to worry about loss of life, and what you worry about is loss of robots, what does that mean for issues of war and peace globally? It’s a big issue.” Sanders is known for his focus on the millionaires and billionaires of the world, and how the U.S. government might favor them. In recent months, he’s turned his attention to AI, which he says is an extension of his primary concerns about wealth inequality.“Today, before we have seen the full implications of robotics and AI, you’re looking at unprecedented wealth and income concentration,” Sanders said. “The top 1% of Americans own more wealth than the bottom 93%,” he said. “All of these zillionaires — the Musks, the Ellisons, the Bezoses, the Zuckerbergs — are investing hundreds and hundreds of billions of dollars into AI and robotics. What is the result of all that?”Elon Musk, the CEO of xAI, was just approved to receive a pay package from one of his other companies, Tesla, that could make him the world’s first trillionaire. “It will mean even more wealth and even more political power for these guys at the top, while our democracy gets weaker and weaker. Working people will see a significant decline in their standard of living unless we turn this around.”Sanders’ focus on AI comes as tech companies have announced historic AI investments and sought to secure goodwill from President Donald Trump. The Trump administration has prioritized ensuring America’s AI ecosystem is “unencumbered by bureaucratic red tape” to avoid an “onerous regulatory regime,” while also keeping many aspects of the Biden administration’s AI efforts.Sanders is not the only elected official bringing attention to the issue, with rising interest in AI legislation at both the state and the federal levels. On Tuesday, a House subcommittee met to discuss the safety of AI chatbots.In the interview with NBC News, Sanders said he sees the issue as an urgent matter and hopes to provoke more discussion about AI and its potential impacts on society: “The folks who have studied this moment are suggesting this ain’t just another technological revolution. It is a lot more profound, and it’s going to move a lot quicker.”With such a fast-moving and general purpose technology as AI, Sanders sees threats not only to workers, but also to larger notions of humanity. “People are worried that right now, many young people, teenagers, are relying on companionship from AI rather than fellow human beings,” Sanders said. “If kids today have AI as their best friends, as the ‘people’ they relate to, where they spend most of their time rather than other human beings, what kind of change does that mean for humanity?”“We’re talking about incredibly deep, deep issues of what it means to be human,” Sanders concluded. “This issue needs enormous discussion, and I hope we can provoke some of it.”Sanders will hold a town hall with “Godfather of AI” and Nobel Laureate Geoffrey Hinton on Tuesday night at Georgetown University to discuss AI’s trajectory, including its effect on workers. “People who know a lot more than I do about this, people like Elon Musk, Bill Gates, Dario Amodei, they are talking about massive, massive job dislocation,” Sanders said. “Musk recently said that ‘AI and robots will replace all jobs. Working will be optional.’”“But what the hell does that mean if it’s going to replace all jobs? If I’m a factory worker today, if I’m working in an office, how am I going to feed my family? How am I going to pay the rent? Who is talking about that?” Sanders added, also referencing recent claims from Anthropic CEO Amodei that AI could eliminate half of all entry-level white-collar jobs and increase unemployment by up to 20% in the next one to five years. “There has been far, far, far too little discussion among the American people, in the media and certainly in Congress about the implications of AI and robotics.”In October, Sanders released a report on AI and led a hearing on AI’s potential to support American workers and families. He’s also proposed a limited set of policies that he says could help address some issues posed by AI, including increased employee ownership of companies, a reduced workweek and even a potential robot tax on large corporations, using “the revenue to improve the lives of workers who have been harmed.”Sanders has also proposed that leading American AI company OpenAI should be broken up given its size. In his interview with NBC News, he said his call “was more general” than just OpenAI and meant to implicate several of America’s largest AI companies.“When I talk about breaking these [companies] up, I mean creating a situation where this new technology is designed to benefit ordinary people, not just designed by a handful of billionaires to make them even richer,” he said.“I don’t have a blueprint in my back pocket here, because nobody has ever had to deal with this reality, but the idea that a handful of multibillionaires can determine the future of humanity seems a little bit crazy to me.”Sanders is also criticizing growing efforts by American venture capitalists and deep-pocketed donors to create super PACs designed to lobby against AI regulation. “You’ve got people who are suggesting that it’s almost anti-religious, the Antichrist, to be demanding regulation of AI and robotics right now,” he said, obliquely referencing recent speeches by Silicon Valley stalwart Peter Thiel. In one of these lectures, Thiel said: “In the 21st century, the Antichrist is a Luddite who wants to stop all science.” “It almost takes you back to the 1700s and the monarchies throughout Europe,” Sanders said. “Some of these Big Tech guys think that they have a God-given right to rule the world, and the idea that a Congress or ordinary citizens might object to what they are doing, they see as something that is unacceptable.”“So they will put unlimited amounts of money into super PACs to elect candidates who will allow them to do whatever they want. It’s very dangerous.”Asked about increasing cooperation between leading American AI companies and the U.S. military, Sanders highlighted growing concerns about privacy. “How far away are we from a small number of people having access to the email that you’ve sent out, every phone call that you’ve been on, really every aspect of your life? We’re not far.”“Either we’re there right now or we certainly assume we’ll be there. That gives the people on top extraordinary control when they have that knowledge,” he said.Sanders joins a growing and bipartisan group of national politicians focusing on AI. Some, like Sen. Josh Hawley, R-Mo., have targeted the societal impacts of AI. Hawley has recently proposed several AI-related bills, including an effort to limit minors’ access to chatbots, a push to better track AI-related layoffs and a mechanism to evaluate AI models’ abilities. Others, including Sens. Elizabeth Warren, D-Mass., and Jim Banks, R-Ind., have proposed bills targeting the export of American AI technology and hardware to China. For his part, Sanders is hoping his voice can help advance the conversation. “I see growing awareness, but I don’t think Congress is moving anywhere near fast enough,” he said. Jared PerloJared Perlo is a writer and reporter at NBC News covering AI. He is currently supported by the Tarbell Center for AI Journalism.
October 9, 2025
Hostage families thank Trump after Israel-Hamas deal
Comments are closed.
Scroll To Top
  • Home
  • Travel
  • Culture
  • Lifestyle
  • Sport
  • Contact Us
  • Politics
© Copyright 2025 - Be That ! . All Rights Reserved